Obvio Health

Obvio Health

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.obviohealth.com

Last Round

Series B

Extension

Jul 25, 2024

Total Funding Raised

$69.4M

Company Overview

ObvioHealth is a healthcare technology company that offers a clinical research platform aimed at improving the efficiency of the trial process by providing better data to sponsors and facilitating virtual clinical trials for participants from the comfort of their homes.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Low-Code/No-Code, Telemedicine, Health IoT

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

decentralized clinical trialsclinical trial platformhybrid clinical trialsdigital clinical trialsremote clinical trialsVirtual Research OrganizationVROeConsentePROno-code platformpatient recruitmentCRO servicesreal-world datawearable integrationtelehealthdigital therapeutics trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Obvio Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Obvio Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJul 25, 2024
Series BJul 1, 2021
Series BMay 20, 2020
Series AMar 23, 2018

Key People

Founding team and executive leadership

Ivan Jarry

Chief Executive Officer

Executive Team

Obvio Health Investors

Notable investors and investment history

InvestorRounds
Tikehau CapitalSeries A
SPRIM Global InvestmentsSeed, Series B
TKS ISeries A
AT Capital GroupSeries B
SPRIM Global InvestmentsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 24, 2026

    Novotech Group selected ObvioGo platform for multi-trial license.

  • Jul 7, 2025

    Added PhRMA, a pharmaceutical trade association, as a customer.

Obvio Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Obvio Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Obvio Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range69
Year Founded2015
Last FundingJul 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.